Pharmacology Watch – February 1, 2017
February 1, 2017
View Archives Issues
-
Report: Access to Biosimilars May Increase Access to Treatment for Cancer Patients Worldwide
A new biosimilar to trastuzumab has proven effective in treating women without prior treatment for ERBB2 (HER2)-positive metastatic breast cancer.
-
Immobilization Affects Drug Treatment of Venous Thromboembolism
Low-molecular-weight heparin is not effective at preventing symptomatic venous thromboembolism after knee arthroscopy or for patients treated during the full period of immobilization due to casting.
-
Ebola Vaccine Shows Promise
An Ebola virus vaccine tested during the recent 2013-2016 outbreak in West Africa appears to be highly effective.
-
Go the Distance When Treating Otitis Media
A recent study revealed that reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment.
-
FDA Actions
In this section: FDA removes black box warning from popular smoking cessation drug, approves treatment for young eczema patients, greenlights drug for spinal muscular atrophy, and links a drug to higher bladder cancer risk.